Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome
- PMID: 1465887
Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome
Similar articles
-
Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.Transplant Proc. 1992 Dec;24(6):2606-8. Transplant Proc. 1992. PMID: 1465881 No abstract available.
-
Influence of bile acid replacement on cyclosporine absorption in a patient with jejunoileal bypass.Pharmacotherapy. 1995 May-Jun;15(3):350-2. Pharmacotherapy. 1995. PMID: 7667169
-
Methotrexate for rejection prophylaxis after heart transplantation.J Heart Lung Transplant. 1995 Sep-Oct;14(5):950-4. J Heart Lung Transplant. 1995. PMID: 8800732 Clinical Trial.
-
Cyclosporine pharmacology.Transplant Proc. 1996 Aug;28(4):2156-8. Transplant Proc. 1996. PMID: 8769185 Review. No abstract available.
-
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].Gastroenterol Clin Biol. 1994;18(2):115-22. Gastroenterol Clin Biol. 1994. PMID: 8013792 Review. French.
Cited by
-
Effect of bile acids on absorption of nitrendipine in healthy subjects.Br J Clin Pharmacol. 2001 Dec;52(6):699-701. doi: 10.1046/j.0306-5251.2001.01489.x. Br J Clin Pharmacol. 2001. PMID: 11736882 Free PMC article. Clinical Trial.
-
Gene co-expression network analysis identifies porcine genes associated with variation in metabolizing fenbendazole and flunixin meglumine in the liver.Sci Rep. 2017 May 2;7(1):1357. doi: 10.1038/s41598-017-01526-5. Sci Rep. 2017. PMID: 28465592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical